Service is in preparation Official β release coming soon. Some features are still being adjusted.

Investical Earnings & investing calendar Earnings & investing calendar
/
OOncolys BioPharma Inc. logo
4588TSE Growth

Oncolys BioPharma Inc.

オンコリスバイオファーマ Yahoo Finance

Recent & upcoming events

Aug 7
Earnings 2:00
Q2 earnings announcement (scheduled)
Add to Google Calendar
May 8
Earnings 2:00
Q1 earnings announcement (scheduled)
Add to Google Calendar
Mar 23
Shareholder meeting Time TBD
Shareholders' meeting
Add to Google Calendar
Feb 6
Earnings 1:00
FY earnings announcement (scheduled)
Add to Google Calendar
Nov 6
Earnings 1:00 approx.
Q3 earnings announcement (scheduled)
Add to Google Calendar
2027
Feb 5
Est.
Earnings 1:00 approx.
Full-year earnings
Add to Google Calendar
May 7
Est.
Earnings 2:00 approx.
Q1 earnings
Add to Google Calendar
Aug 6
Est.
Earnings 2:00 approx.
Q2 earnings
Add to Google Calendar

KPI highlights

FY25
Revenue ¥29M YoY -9.0%
Operating income ¥-2.02B margin -7090.5%
Net income ¥-2.06B YoY —
EPS ¥-80 EPS is sourced from a different data provider than net income (for reference)
P/E —
ROE —

Quarterly fundamentals

Income & cash flow
Quarter FY23 Q3FY23 Q4FY24 Q1FY24 Q2FY25 Q1FY26 Q1
Revenue ——¥0¥31M——
Operating income ——¥-379M¥-414M——
Net income ——¥-364M¥-391M——
Operating CF ——————

Ownership over time

Share of total shares outstanding (disclosed major holdings + undisclosed)（2020–2025）

事業法人 3.4%国内機関 3.2%個人 4.6%未開示 86.6%202020212022202320242025
事業法人国内機関海外機関個人未開示・浮動株

「国内機関」は信託銀行の名義口座（年金・パッシブ・一部海外資本を含む）を集計し、実質保有者へは分解していません。分類は開示名称からの推定です。

Top shareholders — rank & share

アステラス製薬株式会社 2.5%アステラス製薬株式会社モルガン・スタンレーMUFG証券株式 2.2%モルガン・スタンレーMUFG証券株式会社浦田 泰生 1.8%浦田 泰生西田　博行 1%西田　博行株式会社SBI証券 1%株式会社SBI証券今村　均 0.9%今村　均野村證券株式会社 0.9%野村證券株式会社UBS証券株式会社 0.9%UBS証券株式会社中西　均 0.9%中西　均202020212022202320242025

Top shareholders — actual figures (as of 2025)

Holder Shares held Ratio Source
アステラス製薬株式会社 727,200 2.5% Yuho (EDINET)
モルガン・スタンレーMUFG証券株式会社 653,700 2.2% Yuho (EDINET)
浦田 泰生 520,700 1.8% Yuho (EDINET)
YUANTA SECURITIES CO., LTD-RETAIL ACCOUNT 388,400 1.3% Yuho (EDINET)
西田 博行 300,000 1.0% Yuho (EDINET)
株式会社SBI証券 287,714 1.0% Yuho (EDINET)
今村 均 272,200 0.9% Yuho (EDINET)
野村證券株式会社 271,670 0.9% Yuho (EDINET)
UBS証券株式会社 267,454 0.9% Yuho (EDINET)
中西 均 255,100 0.9% Yuho (EDINET)

Source：EDINET（大株主の状況）　Classification inferred from disclosed names

F-Score (Piotroski)

2/9 2 of 9 items lack data

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

✗ Positive ROA ROA -45.2%
✗ Positive operating cash flow ¥-2.11B
✓ ROA improved YoY -52.7% → -45.2%
✗ Operating CF exceeds net income (accrual quality) OCF ¥-2.11B / net income ¥-2.06B
✓ Equity ratio improved* Substitute for the original “decrease in long-term debt” 86.0% → 87.8%
— Current ratio improved No data
✗ No dilution (shares outstanding did not increase) 24,961,600 → 29,291,600
— Gross margin improved No data
✗ Asset turnover improved 0.01× → 0.01×

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY25
Equity ratio —
Current ratio —
Years of positive operating CF 0 of last 6 yrs
Payout ratio 0%
Latest fiscal year result Loss (net loss ¥2.06B)

Performance history

Last 10 years
0億円3億円7億円10億円13億円 FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25

Income & assets

Unit: ¥100M
Item FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Revenue 1.782.291.6913.03.146.429.760.630.310.29
Operating income -8.61-10.8-12.5-5.11-16.7-14.5-12.0-19.3-16.8-20.2
Ordinary income -8.64-10.9-12.3-5.39-17.2-15.0-11.6-19.1-16.6-20.5
Net income -9.31-10.9-12.3-9.12-21.0-16.2-11.5-19.4-16.8-20.6
Total assets 31.435.334.343.828.042.926.520.432.045.6
Equity 26.229.329.034.520.035.921.614.727.540.0

Indicators & cash flow

Unit: ¥100M
Item FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
EPS ————¥-146¥-95¥-66¥-109¥-77¥-80
ROE ——————————
Operating CF ————-17.1-14.9-13.4-17.2-16.7-21.1
Investing CF ————-0.16-0.010.20-0.05-0.05-0.08
Financing CF ————2.4530.9-1.1111.528.932.3
FCF ————-14.7-17.4-17.2-13.4-20.2-19.4

A “—” means data wasn't available for that period — it's not a display error or an unusual value.

Source: EDINET (Annual Securities Report) (fetched 2026-08-29) *Some metrics supplemented from additional sources

Sector positioning

Relative standing within the sector

IR disclosure history

Timely disclosures & annual reports
Is this information incorrect?

Data provided by Twelve Data